| Literature DB >> 30570683 |
Hiba Ali Hasan1,2,3, Emilia Abdulmalek4,5, Mohd Basyaruddin Abdul Rahman6,7, Khozirah Binti Shaari7,8, Bohari Mohd Yamin9, Kim Wei Chan10.
Abstract
BACKGROUND: Although the development of antibiotic and antioxidant manufacturing, the problem of bacterial resistance and food and/or cosmetics oxidation still needs more efforts to design new derivatives which can help to minimize these troubles. Benzimidazo[1,2-c]quinazolines are nitrogen-rich heterocyclic compounds that possess many pharmaceutical properties such as antimicrobial, anticonvulsant, immunoenhancer, and anticancer.Entities:
Keywords: ABTS; Antioxidant; DPPH; Dihydrobenzo[4,5]imidazo[1,2-c]quinazoline; Single crystal
Year: 2018 PMID: 30570683 PMCID: PMC6768020 DOI: 10.1186/s13065-018-0509-z
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Fig. 1Benzimidazoquinazoline scaffold
Fig. 21H-NMR spectrum of OCT
Fig. 313C-NMR of OCT
Fig. 4FTIR spectrum of OCT
Fig. 5DIMS spectrum of OCT with the main fragments
Fig. 6UV–Vis spectrum of OCT
Reaction time and % yield of OCT under conventional reflux and microwave irradiation, respectively
| OCT | Reaction time, min. | % yield | ||||
|---|---|---|---|---|---|---|
| Conventional | MW | % decreased | Conventional | MW | % increase | |
| 75 | 5 | 93 | 77 | 91 | 14 | |
Fig. 7Plausible mechanism for 6-heptyl-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline formation
Fig. 8Fragmentation pattern of OCT
Refinement of structure and crystal data for 6-heptyl-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline
| Identification code | OCT |
|---|---|
| Empirical formula | C21H25N3 |
| Formula weight | 319.20 |
| Temperature | 293 (2) K |
| Wave length | 0.71076 Å |
| Crystal system | Monoclinic |
| Space group | P21/n |
| Unit cell dimensions | a = 9.37 (4) Å α = 90° |
| b = 17.14 (5) Å β = 101.5 (2)° | |
| c = 11.27 (4) Å ɣ = 90° | |
| Volume | 1773 (11) Å3 |
| Z | 4 |
| Density (calculated) | 1.196 Mg/m3 |
| Absorption coefficient | 0.071 mm−1 |
| F(000) | 688 |
| Crystal size | 0.500 × 0.430 × 0.270 mm3 |
| Theta range for data collection | 3.009 to 25.249° |
| Index ranges | − 11 ≤ h ≤ 11, − 20 ≤ k ≤ 20, − 13 ≤ l ≤ 13 |
| Reflections collected | 16,139 |
| Independent reflections | 3186 [R(int) = 0.1192] |
| Completeness to | 99.0% |
| Refinement method | Full-matrix least-squares on F2 |
| Data/restraints/parameters | 3186/1/223 |
| Goodness-of-fit on F2 | 1.046 |
| Final R indices [I > 2 sigma (I)] | R1 = 0.1062, wR2 = 0.2552 |
| R indices (all data) | R1 = 0.1858, wR2 = 0.3193 |
| Extinction coefficient | 0.015 (4) |
| Largest diff. peak and hole | 0.330 and − 0.297 e Å−3 |
| CCDC reference no. | 1830213 |
Fig. 9Molecular structure of OCT compound
Fig. 10The conformation of diazine ring of OCT
Selected bond lengths (Å) and angles (°)
| Bonds | lengths (Å) and angles (°) |
|---|---|
| N1–C7 | 1.439 (7) |
| N2–C7 | 1.465 (8) |
| N2–C14 | 1.348 (8) |
| C1–C14 | 1.455 (8) |
| C6–C1 | 1.421 (8) |
| N1–C6 | 1.375 (7) |
| C6–N1–C7 | 122.2 (5) |
| N1–C7–N2 | 107.2 (5) |
| N1–C7–C15 | 114.2 (5) |
| N2–C7–C15 | 110.9 (5) |
Hydrogen bonds parameters (Å) of OCT compound
| Donor—H…acceptor | D–H (Å) | H…A (Å) | D…A (Å) | D—H…A (°) |
|---|---|---|---|---|
| N1–H1A…N3 | 0.97 (6) | 2.08 (6) | 3.050 (14) | 173 (5) |
i = 1/2 + x, 1/2 − y, 1/2 + z
Fig. 11Molecular packing of OCT compound viewed down a-axis. All hydrogen atoms except hydrogen bonded are omitted for clarity
Fig. 12Fluorescence spectrum of OCT compound
Fig. 13Fluorescence spectrum of AMINE compound
Absorption and emission maxima and quantum yields () for OCT and AMINE compounds
| Compounds | λex (nm) | λem (nm) | Stock shifts (nm) | Quantum yield ( | Quantum yield (%) |
|---|---|---|---|---|---|
| OCT | 360 | 425 | 65 | 0.259 | 26 |
| AMINE | 350 | 414 | 64 | 0.129 | 13 |
| Quinine sulfate | 350 | 458 | 108 | 0.54 | 54 |
Fig. 14DPPH· and ABTS·+ scavenging activity of OCT and AMINE. Results are displayed as mean ± SD (n = 3)
Antimicrobial activities of studied compounds
| Seq. | Compounds concentration in 100 (mg/mL) | Inhibition zone diameter in (mm)a | ||||
|---|---|---|---|---|---|---|
| Target microbes | ||||||
| Gram positive | Gram negative | Fungus | ||||
|
| ||||||
| 1 | OCT | 9 | 7 | – | – | – |
| 2 | AMINE | – | – | – | – | – |
| 3 | +ve controlb | 28.3 | 23.6 | 18.3 | 25 | 26 |
| DMSO (−ve control) | – | – | – | – | – | |
Values are given as mean of triplicate experiment
–, no inhibition was observed
aDiameter of inhibition zones including diameter of 5 mm well
bTetracycline or nystatin in case of antibacterial and antifungal respectively